We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-19 of 19 results
  1. Li-Fraumeni Syndrome

    Li-Fraumeni syndrome (LFS) is a prototypic cancer susceptibility syndrome, resulting from germline pathogenic variants in the tumor suppressor gene,...
    Anita Villani, Thierry Frebourg, David Malkin in The Hereditary Basis of Childhood Cancer
    Chapter 2021
  2. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females

    Background

    The association of genes XRCC1, TP53 and MDM2 with breast cancer (BC) has never been tested in Kyrgyz population. We, therefore, aimed to...

    Jainagul Isakova, Elnura Talaibekova, ... Almaz Aldashev in BMC Cancer
    Article Open access 13 November 2017
  3. Next-generation sequencing of patients with congenital anosmia

    We performed whole exome or genome sequencing in eight multiply affected families with ostensibly isolated congenital anosmia. Hypothesis-free...

    Anna Alkelai, Tsviya Olender, ... Doron Lancet in European Journal of Human Genetics
    Article 13 November 2017
  4. Evaluation of TP53 Pro72Arg and MDM2 SNP285–SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations

    Li-Fraumeni syndrome (LFS) is a rare genetic cancer predisposition disease, partly determined by the presence of a TP53 germline mutation; lacking...

    Francesca Ponti, Serena Corsini, ... Luca Sangiorgi in Familial Cancer
    Article 08 March 2016
  5. SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers

    Background

    The functional single nucleotide polymorphism (SNP) in the MDM2 promoter region, SNP309, is known to be associated with various diseases,...

    Kanako Okamoto, Ryosuke Tsunematsu, ... Kiyoko Kato in BMC Medical Genetics
    Article Open access 21 August 2015
  6. Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis

    Background and Objective

    In Caucasians, the MDM2 single nucleotide polymorphism (SNP) 285 G>C (rs117039649) neutralizes the effect of 309 T>G...

    Andrzej Roszak, Matthew Misztal, ... Pawel P. Jagodziński in Molecular Diagnosis & Therapy
    Article Open access 30 July 2015
  7. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma

    The p53 tumor suppressor and its negative regulator, murine double minute 2 ( MDM2 ), play critical roles in carcinogenesis. P53 codon 72 and MDM2 ...

    Moqin Qiu, Yingchun Liu, ... Hong** Yu in Tumor Biology
    Article 17 October 2015
  8. MDM2 285G>C and 344T>A gene variants and their association with hepatocellular carcinoma: a Moroccan case–control study

    Background

    MDM2 gene polymorphisms 285G/C and 344 T/A are two single nucleotide polymorphisms (SNPs) recently identified as important variants that...

    Khadija Rebbani, Sayeh Ezzikouri, ... Soumaya Benjelloun in Infectious Agents and Cancer
    Article Open access 07 April 2014
  9. Association of p53 and mdm2 in the development and progression of non-small cell lung cancer

    MDM2 protein is an important regulator of the p53 pathway and has a large effect on the anti-tumorigenic activity of the p53. Presently, we aimed to...

    Jamsheed Javid, Rashid Mir, ... Alpana Saxena in Tumor Biology
    Article 12 February 2015
  10. MDM2 SNP309 and risk of cervical cancer

    Stian Knappskog, Per Eystein Lønning in Tumor Biology
    Article 17 April 2014
  11. MDM2 polymorphism associated with the development of cervical lesions in women infected with Human papillomavirus and using of oral contraceptives

    Background

    The MDM2 gene is the major negative regulator of p53, a tumor suppressor protein. Single nucleotide polymorphism in promoter region of MDM2 ...

    Carolina MM Amaral, Katerina Cetkovská, ... Antonio C Freitas in Infectious Agents and Cancer
    Article Open access 18 July 2014
  12. Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers

    Background

    While BRCA mutation carriers possess a 20-40% lifetime risk of develo** ovarian cancer, knowledge about genetic modifying factors...

    Merete Bjørnslett, Stian Knappskog, ... Anne Dørum in BMC Cancer
    Article Open access 05 October 2012
  13. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis

    Background

    The tumor suppressor gene p53 is involved in multiple cellular pathways including apoptosis, transcriptional control, and cell cycle...

    Yan Wan, Wei Wu, ... Baosen Zhou in BMC Cancer
    Article Open access 29 May 2011
  14. MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism

    Introduction

    A functional polymorphism within MDM2, SNP309 T>G, has been linked to early onset cancer. This study examined clinical associations of...

    Fiona EM Paulin, Mary O'Neill, ... Alastair M Thompson in BMC Cancer
    Article Open access 01 October 2008
  15. p53 polymorphisms: cancer implications

    The normal functioning of p53 is a potent barrier to cancer. Tumour-associated mutations in TP53 , typically single nucleotide substitutions in the...

    Catherine Whibley, Paul D. P. Pharoah, Monica Hollstein in Nature Reviews Cancer
    Article 01 February 2009
  16. Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours

    Chromosome 1p is frequently deleted in neuroblastoma (NB) tumours. The commonly deleted region has been narrowed down by loss of heterozygosity...

    H Carén, S Fransson, ... T Martinsson in British Journal of Cancer
    Article Open access 16 October 2007
  17. The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses’ health studies

    Candidate gene association studies to detect breast cancer susceptibility loci have yielded few positive associations. Therefore, it is more likely...

    David G. Cox, Dwayne Deer, ... Immaculata De Vivo in Cancer Causes & Control
    Article 27 March 2007
Did you find what you were looking for? Share feedback.